Yang X - Search Results

1

Development of SOS1 Inhibitor-Based Degraders to Target KRAS-Mutant Colorectal Cancer.

Bian Y, Alem D, Beato F, Hogenson TL, Yang X, Jiang K, Cai J, Ma WW, Fernandez-Zapico M, Tan AC, Lawrence NJ, Fleming JB, Yuan Y, Xie H. Bian Y, et al. Among authors: yang x. J Med Chem. 2022 Dec 22;65(24):16432-16450. doi: 10.1021/acs.jmedchem.2c01300. Epub 2022 Dec 2. J Med Chem. 2022. PMID: 36459180 Free PMC article.

2

Preclinical and Clinical Advances of Targeted Protein Degradation as a Novel Cancer Therapeutic Strategy: An Oncologist Perspective.

Yang X, Yin H, Kim RD, Fleming JB, Xie H. Yang X, et al. Target Oncol. 2021 Jan;16(1):1-12. doi: 10.1007/s11523-020-00782-2. Target Oncol. 2021. PMID: 33369705 Review.

3

Translational relevance of SOS1 targeting for KRAS-mutant colorectal cancer.

Alem D, Yang X, Beato F, Sarcar B, Tassielli AF, Dai R, Hogenson TL, Park MA, Jiang K, Cai J, Yuan Y, Fernandez-Zapico ME, Tan AC, Fleming JB, Xie H. Alem D, et al. Among authors: yang x. Mol Carcinog. 2023 Jul;62(7):1025-1037. doi: 10.1002/mc.23543. Epub 2023 Apr 12. Mol Carcinog. 2023. PMID: 37042566

4

Bibliometric Analyses of the Research Trends of Female Pelvic Organ Prolapse.

Zhang S, Yang Y, Yang X, Zhu X, Tong X, Wu C. Zhang S, et al. Among authors: yang x. Int Urogynecol J. 2024 May 17. doi: 10.1007/s00192-024-05812-5. Online ahead of print. Int Urogynecol J. 2024. PMID: 38758456

5

Inherited CARD9 Deficiency Due to a Founder Effect in East Asia.

Tomomasa D, Lee BH, Hirata Y, Inoue Y, Majima H, Imanaka Y, Asano T, Katakami T, Lee J, Hijikata A, Worakitchanon W, Yang X, Wang X, Watanabe A, Kamei K, Kageyama Y, Seo GH, Fujimoto A, Casanova JL, Puel A, Morio T, Okada S, Kanegane H. Tomomasa D, et al. Among authors: yang x. J Clin Immunol. 2024 May 17;44(5):121. doi: 10.1007/s10875-024-01724-7. J Clin Immunol. 2024. PMID: 38758287

6

Integrating Network Pharmacology and In Vitro Experiments for Assessing the Anti-Tumor Effects of Phyllanthus Urinaria L Anti-neoplastic Decoction in Hepatocellular Carcinoma.

Wei C, Wu Z, Yang X, Jiang X, Wang L, He J, Tong G. Wei C, et al. Among authors: yang x. Altern Ther Health Med. 2024 May 17:AT10123. Online ahead of print. Altern Ther Health Med. 2024. PMID: 38758152

7

Enhancing antitumor immunity with stimulus-responsive mesoporous silicon in combination with chemotherapy and photothermal therapy.

Chen S, Huang R, Shen F, Wu Y, Lin Y, Yang X, Shen J, Fang Y. Chen S, et al. Among authors: yang x. Biomater Sci. 2024 May 17. doi: 10.1039/d4bm00556b. Online ahead of print. Biomater Sci. 2024. PMID: 38758027

8

Applying improved ddPCR to reliable quantification of MPXV in clinical settings.

Liang C, Yang H, Yang X, Long Z, Zhou Y, Wang J, Fan L, Zeng M, Wang Y, Zheng H, Wang Z, Ye P, Lin J, Shi W, Huang H, Yan H, Qian J, Li L, Liu L. Liang C, et al. Among authors: yang x. Microbiol Spectr. 2024 May 17:e0001824. doi: 10.1128/spectrum.00018-24. Online ahead of print. Microbiol Spectr. 2024. PMID: 38757960

9

A comparative study of two thienopyrimidine Schiff base probes for sequential monitoring of Ga³⁺ and Pd².

Shi M, Li B, Kang M, Liu P, Yang X, Pei M, Zhang G. Shi M, et al. Among authors: yang x. Luminescence. 2024 May;39(5):e4773. doi: 10.1002/bio.4773. Luminescence. 2024. PMID: 38757733

10

The 3'UTR Polymorphisms in the NLRP3 Gene Associated with the Risk of COPD and Their Putative Effects on the microRNA Mechanism.

Wu H, Huang C, Zhang Y, Yang X, Peng L, Li W. Wu H, et al. Among authors: yang x. Genet Test Mol Biomarkers. 2024 May 17. doi: 10.1089/gtmb.2023.0229. Online ahead of print. Genet Test Mol Biomarkers. 2024. PMID: 38757624

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68,931 results

Search Page